Archil Jaliashvili: Hemopure and the Future of Oxygen Delivery in Severe Bleeding
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn:
”A patient with catastrophic hemorrhage survived after Cleveland Clinic used Hemopure, when conventional blood transfusion was not an option.
For decades, we spoke about ‘blood substitutes.’
But the real medical target was never blood itself.
The target is oxygen delivery.
We should not only manage hemoglobin numbers.
We must manage tissue oxygenation.
The future of transfusion medicine will not be only about blood.
It will be about precision oxygen delivery.
For emerging BHOC biological hemoglobin oxygen carrier biosimilar and new-generation platforms, this is another important real-world signal that the field is evolving toward solving major global unmet medical needs:
- Severe hemorrhage
- Trauma and emergency care
- Battlefield medicine
- Maternal bleeding
- Organ preservation and perfusion
- Veterinary critical care
- Remote and disaster medicine
Sometimes one clinical case says more than a thousand theoretical discussions.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention